Summit Therapeutics Inc.
SMMT
$18.22
-$0.69-3.65%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -231.79M | -565.71M | -62.91M | -61.20M | -56.25M |
| Total Depreciation and Amortization | 42.00K | 37.00K | 25.00K | 22.00K | 20.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 130.81M | 477.52M | 7.91M | 13.19M | 16.97M |
| Change in Net Operating Assets | 7.86M | 21.41M | -6.19M | -686.00K | 8.97M |
| Cash from Operations | -93.08M | -66.74M | -61.17M | -48.67M | -30.30M |
| Capital Expenditure | -71.00K | 0.00 | -422.00K | -14.00K | -58.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 150.81M | 160.53M | 83.50M | -108.56M |
| Cash from Investing | -71.00K | 150.81M | 160.11M | 83.48M | -108.62M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -24.50M | -75.50M |
| Issuance of Common Stock | 33.81M | 2.22M | 7.68M | 888.00K | 279.64M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 33.81M | 2.22M | 7.68M | -23.61M | 204.14M |
| Foreign Exchange rate Adjustments | 22.00K | 61.00K | 38.00K | -108.00K | 114.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -59.32M | 86.35M | 106.66M | 11.09M | 65.34M |